Clinical Trial Update: Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating KB001-A on time-to-need for antibiotic treatment in cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• KB001-A

Snippet

Sponsor: Humanigen, Inc. | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED